Resources

Our next-generation diagnostic assays have generated novel insights across a broad range of clinical applications.

Access our presentations, publications, and more to see how we’re unlocking the full potential of precision genomics.

Ultra-sensitive ctDNA detection and monitoring in early breast cancer using PhasED-Seq
September 16, 2024 | Poster
Analytical Validation of a Circulating Tumor DNA Assay using PhasED-Seq Technology for Detecting Residual Disease in B-Cell Malignancies
August 9, 2024 | Manuscript
Response-adapted treatment with mosunetuzumab with or without obinutuzumab andpolatuzumab vedotin in treatment naïve follicular and marginal zone lymphoma: interim resultsand PhasED-Seq MRD analysis
June 17, 2024 | Poster
Phased Variants Allow Robust Profiling of Circulating Tumor DNA in Untreated Follicular Lymphomas
December 21, 2023 | Poster
Distinct Hodgkin lymphoma subtypes defined by noninvasive genomic profiling
December 13, 2023 | Manuscript
Prognostic utility of Minimal Residual Disease (MRD)after curative intent induction therapy for DLBCL:A prospective real-world ctDNA study
December 12, 2023 | Presentation